✦ LIBER ✦

Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study

✍ Scribed by Martin-Broto, Javier; Cleeland, Charles S.; Glare, Paul A.; Engellau, Jacob; Skubitz, Keith M.; Blum, Ronald H.; Ganjoo, Kristin N.; Staddon, Arthur; Dominkus, Martin; Feng, Amy; Qian, Yi; Braun, Ada; Jacobs, Ira; Chung, Karen; Atchison, Carolyn

Book ID: 127001328
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 203 KB
Volume: 53
Category: Article
ISSN: 0284-186X
DOI: 10.3109/0284186x.2014.910313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Denosumab Treatment for Giant Cell Tumor

Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II Study

✍ J. Enqellau; S. Chawla; R. Grimer; A. Powell; S. Schuetze; K. Skubitz; A. Staddo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

99 The impact of bone metastases on pain

99 The impact of bone metastases on pain: Results from a phase III denosumab study in men with nonmetastatic castration-resistant prostate cancer

✍ Patrick, D.; Smith, M.R.; Cleeland, C.; Fallowfield, L.; Tombal, B.; Oudard, S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Incidence of acute phase adverse events

Incidence of acute phase adverse events following denosumab or intravenous bisphosphonates: results from a randomized, controlled phase II study in patients with breast cancer and bone metastases

✍ Cynthia Campbell-Baird; Allan Lipton; Makan Sarkeshik; Haijun Ma; Susie Jun 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 131 KB

Effect of daily and intermittent use of

Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: A review of three phase II studies

✍ Ralph C Schimmer; Frieder Bauss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 849 KB

Su2087 Effect of Long-Term Budesonide MM

Su2087 Effect of Long-Term Budesonide MMx 6 mg use on Bone Mineral Density in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study

✍ Travis, Simon; Danese, Silvio; Ballard, E. David; Moro, Luigi; Jones, Richard J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A Phase II safety and effect on time to

A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer

✍ M. Kujundžić; T.J. Vogl; D. Stimac; N. Rustemović; R. Alex Hsi; M. Roh; M. Katič 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB